Peptide therapy for Type I diabetes: the immunological homunculus and the rationale for vaccination
- Cite this article as:
- Cohen, I. Diabetologia (2002) 45: 1468. doi:10.1007/s00125-002-0937-z
- 170 Views
The autoimmune process that produces Type I (insulin-dependent) diabetes mellitus seems to respond favourably to therapeutic vaccination with a peptide of the 60 kDa heat shock protein. This article is a personal review of the observations and the thinking that gave rise to the idea of therapeutic peptide vaccination. The rationale for vaccination therapy is compared to other approaches aimed at specific immunological treatment for autoimmune disease.